About 13 results found for searched term "85-91-6" (0.135 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2033 | GSK 3787 | PPAR |
| GSK3787 | ||
| GSK3787 is an orally available selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6). | ||
| M3189 | TCN-201 | GluR |
| TCN201 | ||
| TCN 201 is a NMDA receptor antagonist for NR1/NR2A and NR1/NR2B with pIC50 of 6.8 and 4.3, respectively. | ||
| M9319 | Dimethyl anthranilate | Apoptosis |
| Methyl 2-(methylamino)benzoate | ||
| Methyl N-methylanthranilate is a pungent compound that can be found in Citrus reticulate Blanco leaves. Dimethyl anthranilate is widely used in the preparation of flavours. | ||
| M6260 | ROC-325 | Autophagy |
| ROC-325 is an orally available novel inhibitor of lysosomal-mediated autophagy which diminishes AML cell viability with the IC50 range of 0.7-2.2 μM. | ||
| M8076 | CP-101606 mesylate | Others |
| CP-101606 mesylate (Traxoprodil mesylate) is a potent noncompetitive antagonist of N-methyl-D-aspartate (NMDA) receptors, selective for the NR2B subunit. | ||
| M9239 | Katacalcin TFA | Peptides |
| PDN 21 TFA | ||
| Katacalcin TFA (PDN 21 TFA) is a potent plasma calcium-lowering peptide. | ||
| M13556 | Necrostatin 2 | RIPK |
| Necrostatin 2 is a potent necroptosis inhibitor. EC50 for inhibition of necroptosis in FADD-deficient Jurkat T cells treated with TNF-α is 0.05 μM. Necrostatin 2 is also a RIPK1 inhibitor. | ||
| M28958 | Mito-TRFS | Fluorescent Dye |
| Mito-TRFS, the first off-on probe, is used to image the mitochondrial thioredoxin reductase (TrxR2) in live cells. | ||
| M29363 | GSK3395879 | TRP Channel |
| GSK3395879 is a selective and orally bioavailable transient receptor potential vanilloid-4 (TRPV4) antagonist with an IC50 of 1 nM for hTRPV4. | ||
| M30699 | MK-0812 Succinate | CCR |
| MK-0812 Succinate is a potent and selective CCR2 antagonist with high affinity at CCR2. | ||
| M40542 | Belantamab Mafodotin | ADC Linker |
| GSK2857916 | ||
| Belantamab Mafodotin is a first-in-class antibody-drug concatenation (ADC) against B cell maturation antigen (BCMA). It contains antibodies targeting BCMA as well as the microtubule inhibitor monomethylauristatin F (MMAF) and may be used in studies related to multiple myeloma (MM). | ||
| M51523 | Katacalcin | Others |
| Katacalcin (PDN 21) is a potent plasma calcium-lowering peptide. | ||
| M56241 | ONO-9780307 | LPL Receptor |
| ONO-9780307 is a specific synthetic LPA1 (lysophosphatidic acid receptor 1) antagonist with an IC50 value of 2.7 nM. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
